Market Research Logo

Norway Pharmaceuticals & Healthcare Q4 2018

Norway Pharmaceuticals & Healthcare Q4 2018

Key View:

Norway's pharmaceutical and healthcare spending will continue to increase over the next 10 years, creatingopportunities for drugmakers and healthcare providers. Moreover, robust economic growth will underpin an improved fiscal outlookover the coming quarters, while the government will continue to support health industries development. That said, Norway’s smallpharmaceutical market size relative to regional peers, combined with cost control measures, will keep a lid on opportunitiespresented to drugmakers.


Key View
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Western Europe Innovative Pharmaceuticals Risk/Reward Index
Norway Innovative Pharmaceuticals Risk/Reward Index
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Norway Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Pharmaceuticals & Healthcare Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report